Peptide record

TPDB11396

Anti-inflammatory Antibacterial Antifungal Toxicity standard
33 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.
TPDB11396
Anti-inflammatory Antibacterial Antifungal Toxicity
Anti-infective peptides Immunity and inflammation peptides Toxicity and safety peptides
Peptipedia AntiBP3 Antifungipept
standard
No
A 33-aa standard natural multi-activity (Anti-inflammatory, Antibacterial, Antifungal, and other sources) peptide sequence curated from Peptipedia, AntiBP3, and Antifungipept, with an available 3D structural model.
Sequence
RKCNFLCKVKNKLKSVGSKSLIGSATHHGIYRV
Physicochemical Analysis
C162H275N51O42S2
DEQMPW
K
3673.40
10.85
10
0
11
+8
6.20
-0.291
88.48
Mammalian: 1 hour Yeast: 2 min E.coli: 2 min
1615
43.96
10
Residue Composition
number
1
A
2
R
2
N
0
D
2
C
0
E
0
Q
3
G
2
H
2
I
3
L
6
K
0
M
1
F
0
P
4
S
1
T
0
W
1
Y
3
V
Amino Acid Distribution
A: 1 R: 2 N: 2 D: 0 C: 2 E: 0 Q: 0 G: 3 H: 2 I: 2 L: 3 K: 6 M: 0 F: 1 P: 0 S: 4 T: 1 W: 0 Y: 1 V: 3
Chemical Descriptors
33
C162H275N51O42S2
3673.40
10.85
+8
6.20
-0.291
Evidence Records 10 records
Evidence 1 Activity

Activity

MIC
Antibacterial
10.2 µM

Target

Escherichia coli ATCC25922

Source & Reference

NA

Other

Active against E. coli ATCC25922 (MIC 10.2 uM), P. aeruginosa ATCC27853 (MIC 10.2 uM), H. pylori 26695 or 11637 (MIC 2.55 uM), and Gram+
Evidence 2 Activity

Activity

MIC
Antibacterial
10.2 µM

Target

Pseudomonas aeruginosa ATCC27853

Source & Reference

NA

Other

Active against E. coli ATCC25922 (MIC 10.2 uM), P. aeruginosa ATCC27853 (MIC 10.2 uM), H. pylori 26695 or 11637 (MIC 2.55 uM), and Gram+ S. aureus ATCC25923 (MIC 20.42 uM). In
Evidence 3 Activity

Activity

MIC
Antibacterial
2.55 µM

Target

H. pylori 26695 or 11637

Source & Reference

NA

Other

Active against E. coli ATCC25922 (MIC 10.2 uM), P. aeruginosa ATCC27853 (MIC 10.2 uM), H. pylori 26695 or 11637 (MIC 2.55 uM), and Gram+ S. aureus ATCC25923 (MIC 20.42 uM). Inactive: B.subtilis, E.faecalis, and S.ep
Evidence 4 Activity

Activity

MIC
Antibacterial
20.42 µM

Target

Staphylococcus aureus ATCC25923

Source & Reference

NA

Other

P. aeruginosa ATCC27853 (MIC 10.2 uM), H. pylori 26695 or 11637 (MIC 2.55 uM), and Gram+ S. aureus ATCC25923 (MIC 20.42 uM). Inactive: B.subtilis, E.faecalis, and S.epidermidis clinical strains (MIC >200 ug/ml)
Evidence 5 Activity

Activity

MIC
Antibacterial
>200 µg/mL

Target

S.epidermidis clinical strains

Source & Reference

NA

Other

uM), and Gram+ S. aureus ATCC25923 (MIC 20.42 uM). Inactive: B.subtilis, E.faecalis, and S.epidermidis clinical strains (MIC >200 ug/ml)
Evidence 6 Activity

Activity

MIC
Antifungal
10.2 µM

Target

Escherichia coli ATCC25922

Source & Reference

Antifungipept

Other

Active against E. coli ATCC25922 (MIC 10.2 uM), P. aeruginosa ATCC27853 (MIC 10.2 uM), H. pylori 26695 or 11637 (MIC 2.55 uM), and Gram+
Evidence 7 Activity

Activity

MIC
Antifungal
10.2 µM

Target

Pseudomonas aeruginosa ATCC27853

Source & Reference

Antifungipept

Other

Active against E. coli ATCC25922 (MIC 10.2 uM), P. aeruginosa ATCC27853 (MIC 10.2 uM), H. pylori 26695 or 11637 (MIC 2.55 uM), and Gram+ S. aureus ATCC25923 (MIC 20.42 uM). In
Evidence 8 Activity

Activity

MIC
Antifungal
2.55 µM

Target

H. pylori 26695 or 11637

Source & Reference

Antifungipept

Other

Active against E. coli ATCC25922 (MIC 10.2 uM), P. aeruginosa ATCC27853 (MIC 10.2 uM), H. pylori 26695 or 11637 (MIC 2.55 uM), and Gram+ S. aureus ATCC25923 (MIC 20.42 uM). Inactive: B.subtilis, E.faecalis, and S.ep
Evidence 9 Activity

Activity

MIC
Antifungal
20.42 µM

Target

Staphylococcus aureus ATCC25923

Source & Reference

Antifungipept

Other

P. aeruginosa ATCC27853 (MIC 10.2 uM), H. pylori 26695 or 11637 (MIC 2.55 uM), and Gram+ S. aureus ATCC25923 (MIC 20.42 uM). Inactive: B.subtilis, E.faecalis, and S.epidermidis clinical strains (MIC >200 ug/ml)
Evidence 10 Activity

Activity

MIC
Antifungal
>200 µg/mL

Target

S.epidermidis clinical strains

Source & Reference

Antifungipept

Other

uM), and Gram+ S. aureus ATCC25923 (MIC 20.42 uM). Inactive: B.subtilis, E.faecalis, and S.epidermidis clinical strains (MIC >200 ug/ml)